跳至主要内容
临床试验/CTRI/2019/05/019131
CTRI/2019/05/019131尚未招募不适用

A Comparative Clinical Study Of Local Application OF LAGHU VISHAGARBHA TAILA AND MARMA THERAPY IN THE MANAGEMENT OF SANDHIGATA VATA w.s.r. TO OSTEOARTHRITISâ€

Uttrakhand Ayurved University1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2019年5月20日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
Moderately improved:51%-75% relief

研究概览

简要总结

Sandigata Vatais a common condition which can be correlated with osteoarthritis. Sandhigatavata  is a common type of Vatic disorderafflicting the society. Owning to distracting nature and difficult anagement atavyadhi has been included in Asht mahagad. Osteoarthritis is a joint failure, adisease in which all structures of the joint have under gone pathology change.This is accompanied by increasing thickness and sclerosis of the subchondralbony plate, by outgrowth of osteophytes at the joint margin, by stretching ofthe articular capsule, by mild synovitis in many affected joints, and by theweakness of muscles bridging the joint. OA is a long term chronic diseasecharacterized by the deterioration of cartilage in joints which result in bonesrubbing together and creating stiffness, pain and impaired movement. Thedisease most commonly affects the joints in the knees, hands, feet, and spineand is related to ageing. It is also associated with a variety of both modifiableand non-modifiable risk factors, including obesity lack of exercise, geneticpredisposition, bone density, occupational injury, trauma and gender.

研究设计

研究类型
Observational

入排标准

年龄范围
30.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • INCLUSION CRITERIA- 1.Patients fulfilling the diagnostic criteria of Sandhigata Vata (OA) 2.Patients aged between 30 -70 years will be included of either sex.

排除标准

  • EXCLUSION CRITERIA- 1.Patients having history of joint trauma, secondary and other systemic illness.
  • 2.Patients suffering from any systemic diseases like tuberculosis, rheumatoid arthritis, gouty arthritis, psoriatic arthritis .
  • 3.Patient suffering from infectious osteoarthritis.

结局指标

主要结局

Moderately improved:51%-75% relief

时间窗: Complete remission:100% relief | Markedly improved:76-99% relief | Moderately improved:51%-75% relief | Improved:26%-50% relief | Unchanged:0% – 25% relief

Complete remission:100% relief

时间窗: Complete remission:100% relief | Markedly improved:76-99% relief | Moderately improved:51%-75% relief | Improved:26%-50% relief | Unchanged:0% – 25% relief

Markedly improved:76-99% relief

时间窗: Complete remission:100% relief | Markedly improved:76-99% relief | Moderately improved:51%-75% relief | Improved:26%-50% relief | Unchanged:0% – 25% relief

Improved:26%-50% relief

时间窗: Complete remission:100% relief | Markedly improved:76-99% relief | Moderately improved:51%-75% relief | Improved:26%-50% relief | Unchanged:0% – 25% relief

Unchanged:0% – 25% relief

时间窗: Complete remission:100% relief | Markedly improved:76-99% relief | Moderately improved:51%-75% relief | Improved:26%-50% relief | Unchanged:0% – 25% relief

次要结局

  • Exacerbation in sign and symptom(90 days)

研究者

发起方
Uttrakhand Ayurved University
申办方类型
Government medical college

研究点 (1)

Loading locations...

相似试验